Bill
Bill > A2811
NJ A2811
NJ A2811Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
summary
Introduced
02/28/2022
02/28/2022
In Committee
02/28/2022
02/28/2022
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
This bill requires the Division of Consumer Affairs in the Department of Law and Public Safety to establish a process by which a patient may request that the patient's prescription monitoring information include an indication that the patient should not be prescribed opioid drugs or other controlled substances with a significant potential for abuse or addiction. The indication would not be included in the patient's prescription monitoring information except at the patient's request. The division would establish a process for removing the indication that a patient should not be prescribed opioid drugs or other controlled substances with a significant potential for abuse or addiction, at the patient's request. The division would also establish a method, for persons who indicate that they should not be prescribed opioid drugs or other controlled substances with a significant potential for abuse or addiction, to communicate this preference, in the event that the person is incapacitated or otherwise unable to communicate this preference prior to or while receiving health care services. The division would develop an education and outreach program for health care providers concerning this process. It is the sponsor's belief that permitting patients to indicate that they should not be prescribed opioids and certain other controlled substances will facilitate the recovery process, help patients maintain sobriety, help avoid the issuance of prescriptions for drugs that could jeopardize the patient's recovery, and assist health care practitioners to identify patients who are at risk of abusing or diverting prescription medications.
AI Summary
This bill requires the Division of Consumer Affairs to establish a process by which a patient can request that their prescription monitoring information include an indication that they should not be prescribed opioid drugs or other controlled substances with a significant potential for abuse or addiction. The indication would only be included in the patient's information at their request, and the division would also establish a process for removing the indication at the patient's request. The division would develop a method for patients who have indicated they should not be prescribed these substances to communicate this preference if they are incapacitated or unable to do so. The division would also create an education and outreach program for healthcare providers on this process. The goal is to facilitate recovery, help patients maintain sobriety, and assist healthcare practitioners in identifying patients at risk of abusing or diverting prescription medications.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Introduced, Referred to Assembly Health Committee (on 02/28/2022)
Bill Topics
Health
- ‐ Drug Abuse, Treatment, and Education
- ‐ Regulation of Drug Industry and Pharmacies
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/A2811 | 02/15/2022 |
| BillText | https://www.njleg.state.nj.us/Bills/2022/A3000/2811_I1.HTM | 03/02/2022 |
| Bill | https://www.njleg.state.nj.us/Bills/2022/A3000/2811_I1.PDF | 03/02/2022 |
Loading...